Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

This grant supports secondary analysis and integration of existing datasets to clarify cancer risk and related outcomes such as prediction, survival, or treatment response. It funds projects that use clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, or molecular data, including innovative methods or novel data combinations.

Amount: up to $200,000
Type: Grant

Key facts

Key facts for Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Amount	up to $200,000
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	EdTech · HealthTech
Deadline	Closes 17 Nov 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 23 hours ago

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026